U.S. PHYSICAL THERAPY INC (USPH)

US90337L1089 - Common Stock

106.4  +1.43 (+1.36%)

After market: 106.4 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
495M
17.02%		553.1M
11.74%		604.802M
9.35%		649.8M
7.44%
EBITDA
YoY % growth
82.29M
23.13%		80.64M
-2.01%		85.251M
5.72%		84.867M
-0.45%
EBIT
YoY % growth
70.7M
25.58%		65.9M
-6.79%		69.556M
5.55%		74.658M
7.34%
Operating Margin
14.28%11.91%11.50%11.49%
EPS
YoY % growth
3.17
11.23%		2.71
-14.51%		2.56
-5.54%		2.83
10.57%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		0.84
11.17%
Revenue
Q2Q % growth		164.38M
8.50%
EBITDA
Q2Q % growth		23.914M
EBIT
Q2Q % growth		21.778M
8.35%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 0.51
-13.56%		0.57-0.06-10.45%
Q4 2023
Q2Q % growth		 0.59
1.72%		0.580.012.08%
Q3 2023
Q2Q % growth		 0.62
6.90%		0.63-0.01-1.43%
Q2 2023
Q2Q % growth		 0.76
-15.56%		0.760.00-0.39%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 155.675M
4.83%		156.43M-755K-0.48%
Q4 2023
Q2Q % growth		 154.801M
9.63%		153.28M1.521M0.99%
Q3 2023
Q2Q % growth		 150M
7.45%		151.89M-1.89M-1.24%
Q2 2023
Q2Q % growth		 151.5M
7.68%		154.08M-2.58M-1.67%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0.21% 0% -4.37%
Revenue0% 0.64% 0% 0.68%